483
New York Fertility Medical Practice, PLLCFDA 483 - New York Fertility Medical Practice, PLLC - May 12, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of New York Fertility Medical Practice, PLLC, a human reproductive tissue establishment in New York, NY, identified a significant issue regarding donor eligibility. The firm failed to determine donors ineligible even after their specimens tested reactive for communicable disease agents. Specifically, an oocyte donor who tested reactive for syphilis was still deemed eligible, and her oocytes were retrieved, fertilized, transferred, and stored.
Open in Dashboard
ID · 7a965670-707a-4aec-89ee-6a86fc7deb6e